{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,17]],"date-time":"2026-05-17T08:24:40Z","timestamp":1779006280739,"version":"3.51.4"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100006928","name":"Ohio State University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006928","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pregnancy Hypertension"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.preghy.2021.09.003","type":"journal-article","created":{"date-parts":[[2021,9,14]],"date-time":"2021-09-14T22:39:59Z","timestamp":1631659199000},"page":"75-78","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Low-dose aspirin increases 15-epi-lipoxins A4 in pregnancies at high-risk for developing preeclampsia"],"prefix":"10.1016","volume":"26","author":[{"given":"Veronica M.","family":"Gonzalez-Brown","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marwan","family":"Ma'ayeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Douglas A.","family":"Kniss","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Cackovic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark B.","family":"Landon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kara M.","family":"Rood","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.preghy.2021.09.003_b0005","doi-asserted-by":"crossref","first-page":"3142","DOI":"10.3390\/biom5043142","article-title":"Immune mechanisms linking obesity and preeclampsia","volume":"5","author":"Spradley","year":"2015","journal-title":"Biomolecules"},{"issue":"4","key":"10.1016\/j.preghy.2021.09.003_b0010","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.semnephrol.2017.05.011","article-title":"Preeclampsia: pathogenesis, prevention, and long-term complications","volume":"37","author":"Jim","year":"2017","journal-title":"Semin. Nephrol."},{"issue":"4","key":"10.1016\/j.preghy.2021.09.003_b0015","doi-asserted-by":"crossref","first-page":"S115","DOI":"10.1016\/j.ajog.2015.08.042","article-title":"Why is placentation abnormal in preeclampsia?","volume":"213","author":"Fisher","year":"2015","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"3","key":"10.1016\/j.preghy.2021.09.003_b0020","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S0002-9378(85)80223-4","article-title":"an imbalance in placental prostacyclin and thromboxane production","volume":"152","author":"Walsh","year":"1985","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"3","key":"10.1016\/j.preghy.2021.09.003_b0025","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1097\/01.ogx.0000256779.06275.c4","article-title":"Inflammatory changes in preeclampsia: current understanding of the maternal innate and adaptive immune response","volume":"62","author":"Visser","year":"2007","journal-title":"Obstet. Gynecol. Surv."},{"key":"10.1016\/j.preghy.2021.09.003_b0030","doi-asserted-by":"crossref","unstructured":"American College of Obstetrics and Gynecologists. Practice Bulletin no. 222: Gestational hypertension and preeclampsia. Obstet Gynecol. 2020; 135(6): e237-e260.","DOI":"10.1097\/AOG.0000000000003891"},{"key":"10.1016\/j.preghy.2021.09.003_b0035","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1111\/j.1365-2125.2011.03943.x","article-title":"Anti-platelet therapy: cyclo-oxygenase inhibition and the use of aspirin with particular regard to dual anti-platelet therapy","volume":"72","author":"Warner","year":"2011","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.preghy.2021.09.003_b0040","first-page":"1119","article-title":"Prostacyclin, thromboxane A and the effect of low-dose ASA in pregnancies at high risk for hypertensive disorders","volume":"83","author":"Vainio","year":"2004","journal-title":"Acta Obstet. Gynecol. Scand."},{"issue":"6","key":"10.1016\/j.preghy.2021.09.003_b0045","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1161\/01.STR.19.6.700","article-title":"Individual variation in platelet aggregability and serum thromboxane B2 concentrations after low-dose aspirin","volume":"19","author":"Tohgi","year":"1988","journal-title":"Stroke"},{"issue":"3-4","key":"10.1016\/j.preghy.2021.09.003_b0050","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/0049-3848(80)90066-3","article-title":"Low dose aspirin and inhibition of thromboxane B2 production in healthy subjects","volume":"17","author":"Patrono","year":"1980","journal-title":"Thromb. Res."},{"issue":"42","key":"10.1016\/j.preghy.2021.09.003_b0055","doi-asserted-by":"crossref","first-page":"15178","DOI":"10.1073\/pnas.0405445101","article-title":"Aspirin triggers antiinflammatory 15-epi-lipoxin A4 and inhibits thromboxane in a randomized human trial","volume":"101","author":"Chiang","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"5","key":"10.1016\/j.preghy.2021.09.003_b0060","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1084\/jem.172.5.1451","article-title":"Formation of lipoxins and leukotrienes during receptor-mediated interactions of human platelets and recombinant human granulocyte\/macrophage colony-stimulating factor-primed neutrophils","volume":"172","author":"Fiore","year":"1990","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.preghy.2021.09.003_b0065","first-page":"93","article-title":"Lipoxin and leukotriene production during receptor-activated interactions between human platelets and cytokine-primed neutrophils","volume":"21A","author":"Fiore","year":"1991","journal-title":"Adv. Prostaglandin Thromboxane Leukot. Res."},{"issue":"11","key":"10.1016\/j.preghy.2021.09.003_b0070","doi-asserted-by":"crossref","first-page":"819","DOI":"10.7326\/M14-1884","article-title":"US Preventive Services Task Force. Low-dose aspirin use for the prevention of morbidity and mortality from preeclampsia: US Preventive Services Task Force recommendation statement","volume":"161","author":"LeFevre","year":"2014","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.preghy.2021.09.003_b0075","unstructured":"American College of Obstetricians and Gynecologists, Task Force on Hypertension in Pregnancy. Hypertension in pregnancy. Report of the American College of Obstetricians and Gynecologists' Task Force on Hypertension in Pregnancy. Obstet. Gynecol. 2013;122(5):1122\u201331."},{"issue":"3","key":"10.1016\/j.preghy.2021.09.003_b0080","doi-asserted-by":"crossref","first-page":"365.e1","DOI":"10.1016\/j.ajog.2017.04.035","article-title":"Impact of USPSTF recommendations for aspirin for prevention of recurrent preeclampsia","volume":"217","author":"Tolcher","year":"2017","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"5","key":"10.1016\/j.preghy.2021.09.003_b0085","doi-asserted-by":"crossref","first-page":"2688","DOI":"10.4049\/jimmunol.170.5.2688","article-title":"Lipoxin A4 and aspirin-triggered 15-epi-lipoxin A4 inhibit human neutrophil migration: comparisons between synthetic 15 epimers in chemotaxis and transmigration with microvessel endothelial cells and epithelial cells","volume":"170","author":"Fierro","year":"2003","journal-title":"J. Immunol."},{"issue":"2","key":"10.1016\/j.preghy.2021.09.003_b0090","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.ajog.2016.09.076","article-title":"The role of aspirin dose on the prevention of preeclampsia and fetal growth restriction: systematic review and meta-analysis","volume":"216","author":"Roberge","year":"2017","journal-title":"Am J Obstet Gyecol."},{"issue":"3","key":"10.1016\/j.preghy.2021.09.003_b0095","doi-asserted-by":"crossref","first-page":"255.e1","DOI":"10.1016\/j.ajog.2019.04.027","article-title":"A pharmacokinetic assessment of optimal dosing, preparation, and chronotherapy of aspirin in pregnancy","volume":"221","author":"Shanmugalingam","year":"2019","journal-title":"Am. J. Obstet. Gyecol."},{"key":"10.1016\/j.preghy.2021.09.003_b0100","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1056\/NEJM199803123381101","article-title":"Low-dose aspirin to prevent preeclampsia in women at high risk. National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units","volume":"338","author":"Caritis","year":"1998","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.preghy.2021.09.003_b0105","doi-asserted-by":"crossref","first-page":"261","DOI":"10.3389\/fimmu.2017.00261","article-title":"Aspirin: the mechanism of action revisited in the context of pregnancy complications","volume":"8","author":"Cadavid","year":"2017","journal-title":"Front. Immunol."},{"issue":"12","key":"10.1016\/j.preghy.2021.09.003_b0110","doi-asserted-by":"crossref","DOI":"10.1210\/clinem\/dgaa642","article-title":"The 15-epilipoxin-A4 pathway with prophylacitc aspirin in preventing preeclampsia: a longitudinal cohort study","volume":"105","author":"Shanmugalingam","year":"2020","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1","key":"10.1016\/j.preghy.2021.09.003_b0115","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.fertnstert.2014.03.056","article-title":"Preeclampsia is associated with a deficiency of lipoxin A4, an endogenous anti-inflammatory mediator","volume":"102","author":"Xu","year":"2014","journal-title":"Fertil. Steril."},{"issue":"5","key":"10.1016\/j.preghy.2021.09.003_b0120","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1016\/S0002-9378(98)70130-9","article-title":"Maternal serum thromboxane B2 concentrations do not predict improved outcomes in high-risk pregnancies in a low-dose aspirin trial. The National Institute of Child Health and Human Development Network of Maternal-Fetal Medical Units","volume":"179","author":"Hauth","year":"1998","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"3","key":"10.1016\/j.preghy.2021.09.003_b0125","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.ajog.2017.11.561","article-title":"Aspirin for the prevention of preterm preeclampsia: systematic review and metaanalysis","volume":"218","author":"Roberge","year":"2018","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.preghy.2021.09.003_b0130","unstructured":"J.T. Henderson, E.P. Whitlock, E. O'Conner, C.A. Senger, J.H. Thompson, M.G. Rowland, Low-dose Aspirin for the Prevention of Morbidity and Mortality from Preeclampsia: A Systematic Evidence Review for the U.S. Preventative Task Force. Rockville (MD): Agency for Healthcare Research and Quality (US);2014. Report No.:14-05207-EF-1."}],"container-title":["Pregnancy Hypertension"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210778921005183?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210778921005183?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:54:30Z","timestamp":1761897270000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2210778921005183"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":26,"alternative-id":["S2210778921005183"],"URL":"https:\/\/doi.org\/10.1016\/j.preghy.2021.09.003","relation":{},"ISSN":["2210-7789"],"issn-type":[{"value":"2210-7789","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Low-dose aspirin increases 15-epi-lipoxins A4 in pregnancies at high-risk for developing preeclampsia","name":"articletitle","label":"Article Title"},{"value":"Pregnancy Hypertension","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.preghy.2021.09.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier B.V. on behalf of International Society for the Study of Hypertension in Pregnancy.","name":"copyright","label":"Copyright"}]}}